CRBP · NASDAQ
Corbus Pharmaceuticals Holdings (CRBP) Stock Price & Fundamentals
Corbus Pharmaceuticals Holdings (CRBP) closed at $1,078.59 on Oct 9, 2026, down 0.70% from the previous close of $1,086.14.
Share price, past year
1Y +51.65%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,078.59 |
| Sep 30, 2026 | $1,057.00 |
| Aug 31, 2026 | $985.73 |
| Jul 31, 2026 | $1,087.65 |
| Jun 30, 2026 | $1,010.79 |
| May 29, 2026 | $1,002.42 |
| Apr 30, 2026 | $953.02 |
| Mar 31, 2026 | $928.54 |
| Feb 27, 2026 | $844.56 |
| Jan 30, 2026 | $774.97 |
| Dec 31, 2025 | $768.74 |
| Nov 28, 2025 | $763.45 |
| Oct 31, 2025 | $759.92 |
Key statistics
- Market cap
- $20.14B
- P/E (TTM)
- —
- EPS (TTM)
- −$6.11
- Revenue (TTM)
- —
- Net income (TTM)
- −$101.90M
- Shares outstanding
- 18.7M
- Dividend yield
- —
- 52-week range
- $711.22 – $1,090.96
Corbus Pharmaceuticals Holdings's market cap is $20.14B, based on a share price of $1,078.59 and 18.7M shares outstanding as of Jun 30, 2026.
Financials
Corbus Pharmaceuticals Holdings reported revenue of $0.00 for fiscal 2022, down 100.00% from fiscal 2021.
Corbus Pharmaceuticals Holdings reported a net loss of $78.54M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2022ended Dec 31, 2022 | $0.00 | −100.0% | −$42.35M | — | −$10.15 | −$37.56M |
| FY2021ended Dec 31, 2021 | $881.71K | −77.6% | −$45.64M | −5,176.4% | −$11.15 | −$48.24M |
| FY2020ended Dec 31, 2020 | $3.94M | −89.1% | −$111.27M | −2,826.1% | −$1.42 | −$100.17M |
| FY2019ended Dec 31, 2019 | $36.14M | +649.5% | −$71.45M | −197.7% | −$1.12 | −$48.46M |
| FY2018ended Dec 31, 2018 | $4.82M | +97.6% | −$55.67M | −1,154.5% | −$0.98 | −$32.37M |
| FY2017ended Dec 31, 2017 | $2.44M | +27.7% | −$32.42M | −1,328.7% | −$0.65 | −$28.50M |
| FY2016ended Dec 31, 2016 | $1.91M | +194.8% | −$20.00M | −1,046.3% | −$0.49 | — |
| FY2015ended Dec 31, 2015 | $648.38K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2022ended Sep 30, 2022 | $0.00 | — | — |
| Q1 FY2022ended Mar 31, 2022 | $0.00 | — | — |
| Q4 FY2021ended Dec 31, 2021 | $0.00 | — | — |
| Q3 FY2021ended Sep 30, 2021 | $97.32K | — | — |
| Q2 FY2021ended Jun 30, 2021 | $136.56K | — | — |
| Q1 FY2021ended Mar 31, 2021 | $647.82K | — | — |
| Q4 FY2020ended Dec 31, 2020 | $658.20K | — | — |
| Q3 FY2020ended Sep 30, 2020 | $1.23M | — | — |
Company profile
- Name
- Corbus Pharmaceuticals Holdings, Inc.
- Ticker
- CRBP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 500 River Ridge Drive, Norwood, MA 02062
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001595097
Recent SEC filings
- Sep 14, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 6, 2026
- May 26, 2026
- May 21, 2026
- May 14, 2026
- May 12, 2026
Frequently asked questions
What is Corbus Pharmaceuticals Holdings's stock price?
Corbus Pharmaceuticals Holdings (CRBP) closed at $1,078.59 on Oct 9, 2026, down 0.70% from the previous close of $1,086.14.
What is Corbus Pharmaceuticals Holdings's market cap?
Corbus Pharmaceuticals Holdings's market cap is $20.14B, based on a share price of $1,078.59 and 18.7M shares outstanding as of Jun 30, 2026.
How much revenue does Corbus Pharmaceuticals Holdings make?
Corbus Pharmaceuticals Holdings reported revenue of $0.00 for fiscal 2022, down 100.00% from fiscal 2021.
Does Corbus Pharmaceuticals Holdings pay a dividend?
Corbus Pharmaceuticals Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Corbus Pharmaceuticals Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures